82 results
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
for the interest for the nine-month period ended December 31, 2023.
Investigation of Patient Assistance Programs
In June 2019, the DOJ (through the U.S … was cooperating with the investigation and in December 2023, Takeda reached a settlement for an amount that is immaterial. The settlement had no material impact
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
Cancer Center and an expert in the management of TTP 1 TAK-755 has not been approved for the use or indications under investigation in clinical trials
S-8
EX-5.1
TAK
Takeda Pharmaceutical Co
28 Jun 23
Registration of securities for employees
6:35am
not made any independent investigation in respect of the matters which are the subject of such assumption or qualification.
Furthermore, our opinion stated
6-K
EX-99.1
2rfguylxj0tmv6 d3
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
xq74 f0e7
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
evc1d
30 May 23
Current report (foreign)
6:11am
6-K
g5w9az3vah
11 Jul 22
Current report (foreign)
6:05am
6-K
EX-99.1
s76ybbteo9u41bnrzl
31 May 22
Current report (foreign)
6:07am
6-K
EX-99.1
ezwjjha inf5eim
31 May 22
Current report (foreign)
12:00am
6-K
4qndj7e8n0xp ktfadio
11 May 22
Current report (foreign)
6:06am
6-K
3v0wmg7 xg7u02v
10 Feb 22
Current report (foreign)
6:03am
6-K
x11a vllostgq2vfd
3 Feb 22
Current report (foreign)
6:09am
6-K
13t d7fx13pmc
5 Nov 21
Current report (foreign)
6:02am
6-K
dg5sgj7rakli58rsayfg
1 Nov 21
Current report (foreign)
6:04am
S-8
EX-5.1
81rvk16k1
28 Oct 21
Registration of securities for employees
6:33am
6-K
il3hm5g
28 Oct 21
Current report (foreign)
6:12am
6-K
2319r4zd
1 Oct 21
Current report (foreign)
6:03am